NCT05575375

Brief Summary

The goals of this study are to determine the (1) feasibility and (2) acceptability of the study procedures through a pilot randomized controlled trial of a values affirmation intervention targeting medication adherence in adults with heart failure enrolled in cardiac rehabilitation relative to usual care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable heart-failure

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 15, 2022

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2025

Completed
10 months until next milestone

Results Posted

Study results publicly available

November 24, 2025

Completed
Last Updated

November 24, 2025

Status Verified

January 1, 2025

Enrollment Period

2.3 years

First QC Date

October 3, 2022

Results QC Date

August 14, 2025

Last Update Submit

November 10, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Acceptability of Intervention and Study Procedures

    Participant self-reported satisfaction with intervention content and delivery \[intervention group only\] and study procedures

    Post-test (2-months)

  • Retention

    Proportion of enrolled participants who completed the final assessment

    2 months

Secondary Outcomes (3)

  • Medication Adherence (Electronically Monitored)

    1 month; calculated as the difference between Baseline and post-test

  • Change in Medication Adherence (Self-report)

    Baseline, post-test (2-months)

  • Medication Adherence (Pill Count)

    Baseline, post-test (2-months)

Other Outcomes (5)

  • Positive and Negative Affect

    Baseline, post-test (2-months)

  • Perceived Stress-4

    Baseline, post-test (2-months)

  • Medication Self-Efficacy

    Baseline, post-test (2-months)

  • +2 more other outcomes

Study Arms (2)

Values Affirmation + Usual Care

EXPERIMENTAL
Behavioral: Values Affirmation + Usual Care

Usual Care

OTHER
Other: Usual Care

Interventions

Participants will engage in a brief values-affirmation exercise to target personal motivation and openness to medication adherence. The interventionist will then review tailored medication education and individual skills training recommendations. The participant's study medication monitoring devices will be labeled with the participants' most important core value(s). Participants will also continue with their usual care.

Values Affirmation + Usual Care

Participants will be asked to continue with their usual care (e.g., cardiac rehabilitation, ongoing medical management)

Usual Care

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Heart failure
  • Enrolled in cardiac rehabilitation
  • Read and understand English

You may not qualify if:

  • Current participation in another medication-monitoring clinical or research protocol
  • New York Heart Association class IV heart failure
  • Diagnosis of Alzheimer's, dementia, or severe cognitive impairment indicated on screening
  • Current suicidality or psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Miriam Hospital

Providence, Rhode Island, 02906, United States

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Results Point of Contact

Title
Emily Gathright
Organization
The Miriam Hospital

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 3, 2022

First Posted

October 12, 2022

Study Start

September 15, 2022

Primary Completion

January 15, 2025

Study Completion

January 15, 2025

Last Updated

November 24, 2025

Results First Posted

November 24, 2025

Record last verified: 2025-01

Locations